Semaglutide treatment attenuates vessel remodelling in ApoE−/− mice following vascular injury and blood flow perturbation

BACKGROUND AND AIMS: Randomized clinical studies have shown a reduction in cardiovascular outcomes with glucagon-like peptide 1 receptor agonist (GLP-1RA) treatment with the hypothesized mechanisms being an underlying effect on atherosclerosis. Here, we aimed to assess the pharmacological effects of...

Descripción completa

Detalles Bibliográficos
Autores principales: Jensen, Ditte Marie, Skovsted, Gry Freja, Bonde, Mathilde Frederikke Bjørn, Bentzon, Jacob Fog, Rolin, Bidda, Franck, Grégory, Ougaard, Maria Katarina Elm, Voetmann, Louise Marie, Bachmann, Julian Christoffer, Uryga, Anna, Pyke, Charles, Kirk, Rikke Kaae, Hvid, Henning, Knudsen, Lotte Bjerre, Lykkesfeldt, Jens, Nyberg, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833261/
https://www.ncbi.nlm.nih.gov/pubmed/36644202
http://dx.doi.org/10.1016/j.athplu.2022.05.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833261/
https://www.ncbi.nlm.nih.gov/pubmed/36644202
http://dx.doi.org/10.1016/j.athplu.2022.05.004

Ejemplares similares